نتایج جستجو برای: triple negative breast cancers

تعداد نتایج: 859949  

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008
Linda Vona-Davis David P Rose Hannah Hazard Marissa Howard-McNatt Farrell Adkins Jessica Partin Gerald Hobbs

BACKGROUND Our objective was to determine the clinicopathologic features of triple-negative (estrogen receptor, progesterone receptor, and human epidermal growth factor-2 receptor negative) breast cancer and their relationship to obesity in women drawn from a population with one of the highest obesity rates in the United States. METHODS This retrospective study involved 620 White patients wit...

2018
Zhang Xiping Chen Bo Yang Shifeng Yu Feijiang Yang Hongjian Cheng Qihui Tang Binbin

Background As a type of new targets for prognosis of malignancies, long non-coding RNA MALAT1 (metastasis-associated lung adenocarcinoma transcription 1) is associated with proliferation and metastatic abilities of several malignancies. However, its relations to development and migration of triple negative and human epidermal growth factor receptor 2 (Her-2) positive breast cancers haven't been...

2018
Yan Guo Hui Yu Jing Wang Quanhu Sheng Shilin Zhao Ying-Yong Zhao Brian D Lehmann

Triple-negative breast cancer (TNBC) is an operational term for breast cancers lacking targetable estrogen receptor expression and HER2 amplifications. TNBC is, therefore, inherently heterogeneous, and is associated with worse prognosis, greater rates of metastasis, and earlier onset. TNBC displays mutational and transcriptional diversity, and distinct mRNA transcriptional subtypes exhibiting u...

Journal: :The journal of breast health 2016
Halil Türkan M Şehsuvar Gökgöz N Serhat Parlak

Metaplastic Breast Cancer (MBC) is a term referring to a heterogeneous group with malignant epithelial and mesenchymal tissue components. MBC is a rare disease, accounting for 0.2% of all breast cancers. Most MBC are triple negative cancers with poor prognosis and an aggressive clinical course. Herein, we aimed to present a 74-year-old patient with metaplastic breast cancer along with clinical,...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2010
Monika Graeser Afshan McCarthy Christopher J Lord Kay Savage Margaret Hills Janine Salter Nicholas Orr Marina Parton Ian E Smith Jorge S Reis-Filho Mitch Dowsett Alan Ashworth Nicholas C Turner

PURPOSE To assess the prevalence of defective homologous recombination (HR)-based DNA repair in sporadic primary breast cancers, examine the clincopathologic features that correlate with defective HR and the relationship with neoadjuvant chemotherapy response. EXPERIMENTAL DESIGN We examined a cohort of 68 patients with sporadic primary breast cancer who received neoadjuvant anthracylcine-bas...

2016
Ovidiu Balacescu Loredana Balacescu Oana Virtic Simona Visan Claudia Gherman Flaviu Drigla Laura Pop Gabriela Bolba-Morar Carmen Lisencu Bogdan Fetica Oana Tudoran Ioana Berindan-Neagoe

Tumors act systemically to sustain cancer progression, affecting the physiological processes in the host and triggering responses in the blood circulating cells. In this study, we explored blood transcriptional patterns of patients with two subtypes of HER2 negative breast cancers, with different prognosis and therapeutic outcome. Peripheral blood samples from seven healthy female donors and 29...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید